Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

IGN523

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T9901A-1914 Copy Product Info
Purity: 95%
🥰Excellent
IGN523 is an anti-CD98 antibody (hCD98, KD = 0.55 nM) that induces antibody-dependent cell-mediated cytotoxicity (ADCC). It permeabilizes lysosomal membranes and inhibits essential amino acid transport function, leading to caspase-3 and caspase-7 mediated apoptosis of tumor cells. IGN523 inhibits tumor growth in various tumor xenograft models and can be used for research on cancers such as non-small cell lung cancer (NSCLC) and acute myeloid leukemia (AML).
IGN523
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$343-In Stock
5 mgInquiry-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
IGN523 is an anti-CD98 antibody (hCD98, KD = 0.55 nM) that induces antibody-dependent cell-mediated cytotoxicity (ADCC). It permeabilizes lysosomal membranes and inhibits essential amino acid transport function, leading to caspase-3 and caspase-7 mediated apoptosis of tumor cells. IGN523 inhibits tumor growth in various tumor xenograft models and can be used for research on cancers such as non-small cell lung cancer (NSCLC) and acute myeloid leukemia (AML).
In vitro
IGN523 strongly induces ADCC activity in Ramos, KG-1, and OCI-AML-3 cells with EC50 values of 18.6 ng/mL, 73.8 ng/mL, and 83.3 ng/mL, respectively, without diminishing ADCC activity within IGN523 cells. Furthermore, IGN523 (2 µg/mL, 0.5-48 hours) triggers caspase-dependent apoptosis, enhances lysosomal membrane permeability, and reduces amino acid transport in these cell lines.
In vivo
IGN523 (15 mg/kg, intraperitoneal injection, weekly, administered either two or three times) is effective in inhibiting tumor growth in Ramos and Dau xenograft mouse models. Furthermore, IGN523 (15 mg/kg, intraperitoneal injection, weekly, administered two, three, or four times) suppresses tumor growth in AML and primary NSCLC xenograft mouse models.
Chemical Properties
Storage & Solubility Information
StorageStore at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion
Related Tags: IGN523 in vivo | IGN523 in vitro